Opportunity Information: Apply for PAR 20 138

The Center of Excellence for Research on Complementary and Integrative Health (CERCIH) funding opportunity (PAR-20-138) is an NIH grant program run through the National Center for Complementary and Integrative Health (NCCIH) that supports large, coordinated research centers built around true multi-project teamwork. The intent is to fund a single integrated program made up of three or more closely connected research projects that gain clear scientific value from being pursued together rather than as separate standalone grants. In practice, NCCIH is looking for centers where the projects inform each other, share expertise and resources, and create measurable synergy, meaning the combined output is stronger, faster, or more innovative than what the same projects could produce independently.

This program uses the P01 mechanism, which is designed for multi-project research and typically includes a leadership and administrative structure to keep the overall effort cohesive. Applications are expected to come from outstanding multidisciplinary teams and to blend multiple research approaches, which could include laboratory, computational, translational, and human mechanistic work, as long as the overall center remains tightly integrated around high-priority scientific questions. A successful application would normally show a unifying theme, strong rationale for why multiple projects must be coordinated, and a plan for how the center will manage shared activities, collaboration, data flow, and quality control across projects.

A key boundary of the announcement is what kinds of human research it will and will not support. The FOA allows studies that involve human participants when the goal is mechanistic understanding, such as research that investigates biological, behavioral, or physiological mechanisms relevant to complementary and integrative health approaches. However, it explicitly does not support clinical trials focused on efficacy or effectiveness. In other words, applicants should not propose trials aimed at proving whether an intervention works in the clinical sense or comparing outcomes the way a typical treatment trial would. The clinical trial language in the title can be confusing, but the main message is that mechanistic human studies may be acceptable while efficacy/effectiveness trials are outside the scope.

All proposed work must align closely with NCCIHs mission and fit within the institutes current Strategic Plan priorities. That means the center theme and each project should address questions that NCCIH views as high relevance and high priority for the field of complementary and integrative health research. The multi-project structure is meant to push beyond incremental work by coordinating different angles on a shared scientific problem, for example by connecting mechanistic studies to preclinical work, biomarkers, or behavioral science in a way that produces integrated conclusions.

Eligibility is broad and includes many types of U.S.-based organizations. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

There are important restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as the applicant organization. At the same time, foreign components are allowed under NIH policy, meaning a U.S. applicant can include certain well-justified foreign collaboration elements as part of the overall project, consistent with the NIH Grants Policy Statement definition of a foreign component.

Administrative details in the posted source indicate this is a discretionary grant in the health category (CFDA 93.213), created on March 16, 2020, with an original closing date listed as May 7, 2023. The award ceiling shown is $1,250,000. The opportunity description does not specify the exact number of expected awards in the provided text, but the intent is clearly to support center-level awards that bundle multiple projects into one coordinated program.

Overall, this opportunity is best suited for teams that already have strong collaborative footing and a compelling, integrated research plan in complementary and integrative health, where at least three projects can be tightly linked to answer a larger question with shared methods, shared resources, and a combined scientific payoff that would be difficult to achieve through separate individual grants.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
  • This funding opportunity was created on 2020-03-16.
  • Applicants must submit their applications by 2023-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 20 138

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: APS-OAA-16-000001/RFA-674-20-000123

Previous opportunity: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 20 138

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 20 138) also looked into and applied for these:

Funding Opportunity
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) Apply for PA 20 141

Funding Number: PA 20 141
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) Apply for RFA HG 20 015

Funding Number: RFA HG 20 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) Apply for RFA HG 20 014

Funding Number: RFA HG 20 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) Apply for RFA HG 20 016

Funding Number: RFA HG 20 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) Apply for RFA AI 20 007

Funding Number: RFA AI 20 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $900,000
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Centers (U01 Clinical Trial Not Allowed) Apply for RFA HG 20 001

Funding Number: RFA HG 20 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed) Apply for RFA DC 20 001

Funding Number: RFA DC 20 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 20 024

Funding Number: RFA AI 20 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) Apply for PAR 20 150

Funding Number: PAR 20 150
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Tuberculosis Research Units (U19 Clinical Trial Optional) Apply for RFA AI 20 020

Funding Number: RFA AI 20 020
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,800,000
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) Apply for PAR 20 152

Funding Number: PAR 20 152
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) Apply for PAR 20 154

Funding Number: PAR 20 154
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Apply for PAR 20 153

Funding Number: PAR 20 153
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) Apply for PAR 20 156

Funding Number: PAR 20 156
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) Apply for PAR 20 157

Funding Number: PAR 20 157
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PAR 20 158

Funding Number: PAR 20 158
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 20 159

Funding Number: PAR 20 159
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Furthering Health System Reforms in Ukraine Apply for RFI 121 20 000001

Funding Number: RFI 121 20 000001
Agency: Ukraine USAID-Kiev
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Clinical Trial Optional) Apply for RFA AA 20 008

Funding Number: RFA AA 20 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $175,000
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 20 525

Funding Number: RFA MH 20 525
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 138", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: